Disruption of the AR/ZNF217/PROM2 axis sensitizes prostate cancer to ferroptosis and enzalutamide therapy

These authors contributed equally: Wenjun Hao, Peng Liang, Wanglong Zheng, Minglu Sheng.

Comments (0)

No login
gif